OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition
Oncostatin M (OSM) is a member of the interleukin-6 (IL-6) family of cytokines and can bind two different receptors, Leukemia inhibitory factor receptor (LIFR) and Oncostatin M receptor (OSMR), through a complex containing the common glycoprotein 130 (gp130) subunit [...]
Main Authors: | Francesca Lantieri, Tiziana Bachetti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/19/11096 |
Similar Items
-
OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling
by: Yizhou Feng, et al.
Published: (2023-04-01) -
Molecular Simulation of Oncostatin M and Receptor (OSM–OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease
by: Qingqing Du, et al.
Published: (2020-03-01) -
Cellular Senescence in Physiological and Pathological Processes
by: Mauro Finicelli, et al.
Published: (2022-11-01) -
The <i>OSMR</i> Gene Is Involved in Hirschsprung Associated Enterocolitis Susceptibility through an Altered Downstream Signaling
by: Tiziana Bachetti, et al.
Published: (2021-04-01) -
Reactive Sulfur Species (RSS) in Physiological and Pathological Conditions and in Therapy
by: Anna Bilska-Wilkosz, et al.
Published: (2022-08-01)